Cargando…
Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B
A few studies showed that long-term methotrexate (MTX) use exacerbates liver fibrosis and even leads to liver cirrhosis in rheumatoid arthritis (RA) patients. We therefore conducted a population-based cohort study to investigate the impact of long-term MTX use on the risk of chronic hepatitis B (CHB...
Autores principales: | Tang, Kuo-Tung, Hung, Wei-Ting, Chen, Yi-Hsing, Lin, Ching-Heng, Chen, Der-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772158/ https://www.ncbi.nlm.nih.gov/pubmed/26928373 http://dx.doi.org/10.1038/srep22387 |
Ejemplares similares
-
Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C
por: Tang, Kuo-Tung, et al.
Publicado: (2016) -
Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate
por: Lee, Sang-Won, et al.
Publicado: (2012) -
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022) -
Increased Encapsulation Efficiency of Methotrexate in Liposomes for Rheumatoid Arthritis Therapy
por: Guimarães, Diana, et al.
Publicado: (2020) -
Primary Hepatic Lymphoma in a Patient with Rheumatoid Arthritis Treated with Methotrexate
por: Tatsumi, Goichi, et al.
Publicado: (2014)